ORIGINAL RESEARCH article
Front. Immunol.
Sec. Microbial Immunology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1576995
This article is part of the Research TopicAdvances in Immunity and Microbiome: Exploring Key Interactions and InnovationsView all 4 articles
Generation of a new Paneth Cell specific Cre recombinase transgenic mouse line
Provisionally accepted- 1Center for Inflammation Research, Flanders Institute for Biotechnology, Ghent, East Flanders, Belgium
- 2Department of Biomedical Molecular Biology, Ghent University, Gent, Belgium
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Paneth cells are located in the crypts of Lieberkühn in mammalian small intestines and are producing antimicrobial peptides to keep the microbiome under control. The genetic manipulation of Paneth cells, their tracking and depletion depends on a solid Paneth cell specific Cre transgenic line. Here we describe bulk RNAseq-based expression data from pure, sorted Paneth cells of C57BL/6J mice, and identify several strongly expressed Paneth cell specific genes, the expression of which is stable under pathophysiological conditions, as well as in duodenum, jejunum and ileum. We selected the Defa24 gene regulatory sequences and generated a new Defa24iCre transgenic line using BAC technology, Tg(Defa24-icre)Cli. The resulting transgenic line provides robust expression and allows for the complete depletion of Paneth cells by cell ablation, yielding mice without any detectable lysozyme biological activity in the small intestines.
Keywords: Paneth Cells, Defa24iCre, Defensins, Cre-recombinase transgenic mouse model, Cre/loxP Defa24 iCre
Received: 14 Feb 2025; Accepted: 26 May 2025.
Copyright: © 2025 Garcia-Gonzalez, Wallaeys, Toussaint, Hochepied, Dewaele, De Beul, Timmermans and Libert. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Claude Libert, Center for Inflammation Research, Flanders Institute for Biotechnology, Ghent, 9052, East Flanders, Belgium
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.